Skip to main content
Figure 5 | Cancer Cell International

Figure 5

From: Suramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expression

Figure 5

Viability decrease in Hela cells treated with 0, 50, 100 and 200ug/ml Suramin (a,b,c,d). The results represent the mean ± the Standard deviation (SD) of all independent experiments performed in triplicate. Statistical analysis, the one-way ANOVA. * P < 0.0 50 μg/ml 48 h vs 50 μg/ml 72 h; 50 μg/ml 72hs vs 50 μg/ml 96 h (b). P < 0.05 100 μg/ml 48hs vs 100 μg/ml ;100 μg/ml 72 h vs 100 μg/ml 96 h (c). ♦ P < 0.05 200 μg/ml 48 h vs 200 μg/ml 72 h; 200 μg/ml 72 h vs 200 μg/ml 96 h (d).

Back to article page